Skip to main content

Peer Review reports

From: Newly diagnosed multiple myeloma patients with CD56 expression benefit more from autologous stem cell transplantation

Original Submission
18 Sep 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
18 Oct 2022 Reviewed Reviewer Report
23 Oct 2022 Reviewed Reviewer Report
14 Nov 2022 Author responded Author comments - Wenming Chen
Resubmission - Version 3
14 Nov 2022 Submitted Manuscript version 3
Publishing
29 Nov 2022 Editorially accepted
23 Dec 2022 Article published 10.1186/s12885-022-10382-0

You can find further information about peer review here.

Back to article page